Feature Channels:

Drug Resistance

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Antibiotic Resistance, University of Birmingham

New Study Links Antibiotic Resistance to Common Household Disinfectant Triclosan

Triclosanrelease.jpg

Scientists from the University of Birmingham and Norwich Research Park have discovered a link between a major mechanism of antibiotic resistance and resistance to the disinfectant triclosan which is commonly found in domestic products.

Medicine

Science

Channels:

New System Makes Fast, Customized Antibiotic Treatments Possible

Using nanotechnology, image processing tools and statistical analysis, Technion researchers have developed a system that enables faster diagnostics, earlier and more effective treatment of infectious bacteria, and improved patient recovery times.

Medicine

Channels:

antibiotic resisistance, antibiotic resistant drugs, Sepsis, Viral Infection, NHS

New Research Into Antibiotic Treatment for Killer Sepsis

gavinperkins2.jpg

University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face – antibiotic resistance.

Science

Channels:

antibiotic resisistance, Genomics, Ecology, Center for Ecosystem Science and Society, Bacteria, Food animal production, Translational Genomics Research Institute

Ecologist: Tracking Bacterial Movement Between Humans, Animals Key to Understanding Antibiotic Resistance

Koch_Figure_1.jpg

Benjamin Koch and his co-authors treated bacteria the way they would any ecosystem, using genomic "tags" to track bacterial transmission.

Medicine

Channels:

Finding the Perfect Match: A New Approach to Battle Drug-Resistant Bacteria

Antibiotics were the wonder drug of the 20th century, but bacteria evolved resistance. According to the CDC, more than 2 million people in the U.S. develop MDR infections every year. Researchers at Univ. of Utah developed a rapid screen to pair existing FDA-approved drugs to combat MDR infections.

Medicine

Channels:

Microbiome, Antibiotics, antiseptics

Penn Study Details Impact of Antibiotics, Antiseptics on Skin Microbiomes

GriceGramStain.jpg

The use of topical antibiotics can dramatically alter communities of bacteria that live on the skin, while the use of antiseptics has a much smaller, less durable impact. The study, conducted in mice in the laboratory of Elizabeth Grice, PhD, an assistant professor of Dermatology in the Perelman School of Medicine at the University of Pennsylvania, is the first to show the long-term effects of antimicrobial drugs on the skin microbiome.

Medicine

Channels:

UTI, Urinary Tract Infection , E. Coli, Mannose

UTI Treatment Reduces Gut E. Coli, May Offer Alternative to Antibiotics

UPEC-Image-1_forweb.jpg

Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract. A new study from Washington University School of Medicine in St. Louis has found that a molecular decoy can reduce the numbers of UTI-causing bacteria in the gut, potentially reducing the risk of recurrent UTI.

Medicine

Channels:

GW School of Medicine and Health Sciences, Global Health, Parisitology, Tropical Medicine, Immunology, Vaccine Development, Drug Resistance, Hookworm, hookworm vaccine

GW Receives $3 Million Grant to Test Hookworm Vaccine Efficacy in Phase II Clinical Trial

GW Researchers received a $3 million U01 grant from the National Institutes of Health to test the efficacy of a candidate recombinant hookworm vaccine, the next step in their goal to fight hookworm.

Business

Channels:

UMB, Serenta License Agreement Welcomed in Quest To Combat Deadly Antibiotic-Resistant Staph Infections

mark_1.jpg

UMB grants licensing rights for new vaccine candidate to Serenta Biotechnology, LLC, whose co-founder, Mark Shirtliff, PhD, professor at the University of Maryland School of Dentistry and the UM School of Medicine.

Medicine

Science

Channels:

MRSA, Infection, Health, Medicine, Disease

New Antibiotic Packs a Punch Against Bacterial Resistance

PNAS_Paper_Summary_5_23_17.jpg

Scientists at The Scripps Research Institute (TSRI) have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come.







Chat now!